Inhaled insulin vs injections for gestational diabetes
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial compares an inhaled insulin (Afrezza) to insulin injections for managing blood sugar after meals in women with gestational diabetes. The goal is to see if the inhaled option works as well and is easier to use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 40 years old with a single baby at 24 to 34 weeks of pregnancy.
- You have been diagnosed with gestational diabetes and are already using rapid-acting insulin injections for breakfast (less than 20 units).
- You had a BMI (a measure of body size) between 25 and 45 before pregnancy or in the first trimester.
- You are able to read and speak English and give your consent for the study.
- You do not have type 1 or type 2 diabetes, or any other major lung or heart condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an inhaled insulin called Afrezza for teenagers and children who have just been diagnosed with type 1 diabetes. It aims to see if this new way of taking insulin can help manage blood sugar and fit into their lives.
This trial tests whether a new inhaled insulin (Technosphere) causes fewer low blood sugar episodes during exercise compared to standard injected insulin in people with type 1 diabetes who use an automated insulin pump. It may help you avoid hypoglycemia while staying active.
This study compares two common medicines (metformin pills and insulin shots) to see which works better for controlling blood sugar in pregnant women with gestational diabetes. The goal is to find the best treatment for both mom and baby, now and in the long term.
This trial compares two medicines—metformin pills and insulin shots—to see which works better for controlling blood sugar in gestational diabetes. You may be able to join if you have gestational diabetes that needs treatment and are willing to take either medicine.
This trial compares two types of insulin (glargine and NPH) to see which works better for managing blood sugar in pregnant women with gestational diabetes or type 2 diabetes. If you need to start insulin during pregnancy, you may be able to join.
This trial compares two once-daily insulin injections to see which works better and is safer for people with type 2 diabetes. Both are new types of insulin designed to help control blood sugar with fewer side effects.
Hear when a new Pregnancy Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.